YS Biopharma Co., Ltd. (YS) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Beijing, 中国. 现任CEO为 Hui Shao.
YS 拥有 IPO日期为 2021-08-05, 773 名全职员工, 在 NASDAQ Capital Marke, 市值为 $192.09M.
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
